The number of publications about dengue fever has grown strongly since 1960 reflecting strong growth in the number of global cases.
World Health Organization (WHO) recommendations on the use of dengue vaccine
Dengue vaccination would be cost-effective in Brazil even with a relatively low vaccine efficacy in seronegative individuals
São João del Rei has recorded another death from dengue fever - the second in 2016 so far.
Epidemiological bulletin showed the increase in the number of reported cases of dengue in Uberlândia. There were 1,862 new cases in three months.
Lessons learned in health communication and risk management of Chikungunya virus and other vector-born diseasesby Jair Vega et al.
Review of articles on communication strategies for vector-borne diseases
Outwitting dengue threat and epidemics resurgence in Asia-Pacific countries: strengthening integrated dengue surveillance, monitoring and response systemsby Tambo E et al.
Strengthening integrated dengue surveillance, monitoring and response systems
Evaluation of NS1 Antigen Detection for Early Diagnosis of Dengue in a Tertiary Hospital in Southern Indiaby Anand AM et al.
Evaluation of NS1 antigen assay as an alternative to RT-PCR for the early diagnosis of dengue
The Use of a Dengue Rapid Diagnostic Test During Suspected Dengue Outbreaks in Resource Limited Regionsby Hunsperger EA et al.
Evaluation of rapid diagnostic test for dengue virus
Analysis of potential dengue vaccine impact in Yucatán Mexico.
A study of dengue and yellow fever viruses in mosquitoes in Zaria, Nigeria
The growth of slums in the developing world's rapidly expanding cities is creating new opportunities for infectious disease to flourish and spread.
Estimating the public health importance of the CYD-tetravalent dengue vaccine: Vaccine preventable disease incidence and numbers needed to vaccinateby Bradford D. Gessner, Annelies Wilder-Smith
Vaccine efficacy alone is inadequate to capture the public health importance of vaccines.
Laboratory systems and diagnostic technologies are a critical pillar in the fight against malaria. The World Health Organization (WHO) recommends diagnostic testing for all people with suspected malaria before treatment is administered.
An estimate of the global economic burden of dengue by country and super-region
This paper looks at the true cost of dengue fever
Real-time dengue surveillance is critical for identifying areas where transmission is ongoing or likely to occur so that interventions can be optimized. Sophisticated new tools can help - and so can you.
Secondary analysis of clinical trial data reveals dengue burden
Vector control, surveillance, drugs, diagnostics and vaccines all hold exciting potential but none can solve the problem alone. We need an integrated approach.